(*) CA Approval Date: 2020. 10.07.
(*) USA Launch Date: 2020. 06.01.
>Receptor Modulator Capsules
Company
Generic Name: Ozanimod Capsules
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2021. 05.18.
S1P: Sphingosine-1-Phosphate
TradeMark
TradeMark Web-Site